Roche NimbleGen introduces enhanced whole exome sequencing solution for medical and translational research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Roche NimbleGen introduced an enhanced whole exome sequencing solution for medical and translational research.

Roche announced the global launch of the SeqCap EZ MedExome Target Enrichment Kit, a comprehensive whole exome sequencing solution designed to increase the discovery and detection of human genetic variants associated with disease while reducing sequencing costs.

Pekka Ellonen, head of the sequencing unit for the Institute for Molecular Medicine Finland at the University of Helsinki, said, “We have evaluated a number of target enrichment systems for whole exome sequencing.

The kit is labeled “for research use only. It isn’t approved for diagnostic procedures.

Table of Contents

YOU MAY BE INTERESTED IN

“Backwater to Blockbuster,” the first de novo book published by the Cancer History Project, traces the evolution of St. Jude Children’s Research Hospital to its current status of a powerhouse of research in pediatric cancer.

The U.S. Department of Justice issued a letter alleging that Yale Medical School of violating anti-discrimination laws and instititing policies that disadvantaged white and Asian applicants while favoring Black and Hispanic applicants.  The DOJ investigation, which was launched a year ago, reviewed the school’s admission policies for the class of 2023, 2024, and 2025, the...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login